Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 10/2012

01.10.2012 | Original Article

Clinical Significance of Incidental Colonic 18F-FDG Uptake on PET/CT Images in Patients with Gastric Adenocarcinoma

verfasst von: Jung Ho Shim, Joo Hyun O, Seong Il Oh, Han Mo Yoo, Hae Myung Jeon, Cho Hyun Park, Sung Hoon Kim, Kyo Young Song

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Background and Objectives

We assessed the ability of positron emission tomography–computed tomography (PET/CT) to detect synchronous colonic pathology and determined the significance of 18F-fluorodeoxyglucose (18F-FDG) activity in the colon of gastric cancer patients.

Methods

A total of 239 gastric cancer patients who underwent PET/CT and colonoscopy preoperatively were included. FDG uptake patterns on PET/CT were classified as (1) group A, focal; (2) group B, diffuse; and (3) group C, no uptake. The PET/CT findings were compared with the results of concurrent colonoscopy.

Results

In group A, a total of 123 polyps of >0 mm were observed. Of these, nine polyps were colonic adenocarcinomas and six were high-grade dysplasia. The incidence of colonic adenocarcinomas was significantly higher in group A than in the other two groups (p = 0.037). There was a significant correlation between SUVmax values and incidence of colonic polyps of >10 mm (r = 0.471, p = 0.04). The distribution pattern of SUVmax in polyps with adenoma (>10 mm) was less homogenous than in polyps (>10 mm) with adenocarcinoma.

Conclusions

The focal colonic FDG uptake in PET/CT requires colonoscopic confirmation. The suspicion of colonic malignancy increased in the presence of polyps >10 mm that showed a positive correlation with the SUVmax.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P.: Global Cancer Statistics: 2002. CA Cancer J Clin 2005; 55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P.: Global Cancer Statistics: 2002. CA Cancer J Clin 2005; 55:74–108.PubMedCrossRef
2.
Zurück zum Zitat Kelley JR, Duggan JM.: Gastric Cancer Epidemiology and Risk Factor. J Clin Epidemiol 2003; 56: 1–9.PubMedCrossRef Kelley JR, Duggan JM.: Gastric Cancer Epidemiology and Risk Factor. J Clin Epidemiol 2003; 56: 1–9.PubMedCrossRef
4.
Zurück zum Zitat Miller FH, Kochman ML, Talamonti MS, et al.: Gastric Cancer. Radiologic Staging. Radiol Clin North Am 1997; 35:331–349.PubMed Miller FH, Kochman ML, Talamonti MS, et al.: Gastric Cancer. Radiologic Staging. Radiol Clin North Am 1997; 35:331–349.PubMed
5.
Zurück zum Zitat Park CH, Song KY, Kim SN.: Treatment Results for Gastric Cancer Surgery: 12 Years' Experience at a Single Institute in Korea. Eur J Surg Oncol 2008; 34:36–41.PubMedCrossRef Park CH, Song KY, Kim SN.: Treatment Results for Gastric Cancer Surgery: 12 Years' Experience at a Single Institute in Korea. Eur J Surg Oncol 2008; 34:36–41.PubMedCrossRef
6.
Zurück zum Zitat Kim SK, Kang KW, Lee JS, et al.: Assessment of Lymph Node Metastases using 18F-FDG PET in Patients with Advanced Gastric Cancer. Eur J Nucl Med Mol Imaging 2006; 33:148–155.PubMedCrossRef Kim SK, Kang KW, Lee JS, et al.: Assessment of Lymph Node Metastases using 18F-FDG PET in Patients with Advanced Gastric Cancer. Eur J Nucl Med Mol Imaging 2006; 33:148–155.PubMedCrossRef
7.
Zurück zum Zitat Yeung HW, Macapinlac H, Karpeh M, et al.: Accuracy of FDG-PET in Gastric Cancer. Preliminary Experience. Clin Positron Imaging 1998; 1:213–221.PubMedCrossRef Yeung HW, Macapinlac H, Karpeh M, et al.: Accuracy of FDG-PET in Gastric Cancer. Preliminary Experience. Clin Positron Imaging 1998; 1:213–221.PubMedCrossRef
8.
Zurück zum Zitat Chen J, Cheong JH, Yun MJ, et al.: Improvement in Preoperative Staging of Gastric Adenocarcinoma with Positron Emission Tomography. Cancer 2005; 103:2383–2390.PubMedCrossRef Chen J, Cheong JH, Yun MJ, et al.: Improvement in Preoperative Staging of Gastric Adenocarcinoma with Positron Emission Tomography. Cancer 2005; 103:2383–2390.PubMedCrossRef
9.
Zurück zum Zitat Song KY, Park SM, Kim SN, Park CH.: The Role of Surgery in the Treatment of Recurrent Gastric Cancer. Am J Surg 2008; 196:19–22.PubMedCrossRef Song KY, Park SM, Kim SN, Park CH.: The Role of Surgery in the Treatment of Recurrent Gastric Cancer. Am J Surg 2008; 196:19–22.PubMedCrossRef
10.
Zurück zum Zitat Maehara Y, Hasuda S, Koga T, et al.: Postoperative Outcome and Sites of Recurrence in Patients following Curative Resection of Gastric Cancer. Br J Surg 2000; 87:353–357.PubMedCrossRef Maehara Y, Hasuda S, Koga T, et al.: Postoperative Outcome and Sites of Recurrence in Patients following Curative Resection of Gastric Cancer. Br J Surg 2000; 87:353–357.PubMedCrossRef
11.
Zurück zum Zitat Otsuji E, Yamaguchi T, Sawai K, et al.: Recent Advances in Surgical Treatment have Improved the Survival of Patients with Gastric Carcinoma. Cancer 1998; 82:1233–1237.PubMedCrossRef Otsuji E, Yamaguchi T, Sawai K, et al.: Recent Advances in Surgical Treatment have Improved the Survival of Patients with Gastric Carcinoma. Cancer 1998; 82:1233–1237.PubMedCrossRef
12.
Zurück zum Zitat Cook GJR, Fogelman I, Maisey MN.: Normal Physiological and Benign Pathological Variants of 18-Fluoro-Deoxyglucose Positron Emission Tomography Scanning: Potential for Error in Interpretation. Semin Nucl Med 1996; 26:308–314.PubMedCrossRef Cook GJR, Fogelman I, Maisey MN.: Normal Physiological and Benign Pathological Variants of 18-Fluoro-Deoxyglucose Positron Emission Tomography Scanning: Potential for Error in Interpretation. Semin Nucl Med 1996; 26:308–314.PubMedCrossRef
13.
Zurück zum Zitat Kostakoglu L, Hardoff R, Mirtcheva R, et al.: PET-CT Fusion Imaging in Differentiating Physiologic from Pathologic FDG Uptake. Radiographic 2004; 24:1411–1431.CrossRef Kostakoglu L, Hardoff R, Mirtcheva R, et al.: PET-CT Fusion Imaging in Differentiating Physiologic from Pathologic FDG Uptake. Radiographic 2004; 24:1411–1431.CrossRef
14.
Zurück zum Zitat Gutman F, Alberini JL, Wartski M, et al.: Incidental Colonic Focal Lesions Detected by FDG PET/CT. AJR Am J Roentgenol 2005; 185:495–500.PubMedCrossRef Gutman F, Alberini JL, Wartski M, et al.: Incidental Colonic Focal Lesions Detected by FDG PET/CT. AJR Am J Roentgenol 2005; 185:495–500.PubMedCrossRef
15.
Zurück zum Zitat Kamel EM, Thumshirn M, Truninger K, et al.: Significance of Incidental 18 F-FDG Accumulation in the Gastrointestinal Tract in PET/CT: Correlation with Endoscopic and Histopathologic Results. J Nucl Med 2004; 45:1804–1810.PubMed Kamel EM, Thumshirn M, Truninger K, et al.: Significance of Incidental 18 F-FDG Accumulation in the Gastrointestinal Tract in PET/CT: Correlation with Endoscopic and Histopathologic Results. J Nucl Med 2004; 45:1804–1810.PubMed
16.
Zurück zum Zitat Israel O, Yefremov N, Bar-Shalom R, et al.: PET/CT Detection of Unexpected Gastrointestinal Foci of 18-F-FDG Uptake: Incidence, Localization Patterns, and Clinical Significance. J Nucl Med 2005; 46:758–762.PubMed Israel O, Yefremov N, Bar-Shalom R, et al.: PET/CT Detection of Unexpected Gastrointestinal Foci of 18-F-FDG Uptake: Incidence, Localization Patterns, and Clinical Significance. J Nucl Med 2005; 46:758–762.PubMed
17.
Zurück zum Zitat Agress H, Cooper BZ.: Detection of Clinically Unexpected Malignant and Premalignant Tumors with Whole-Body FDG-PET: Histopathology Comparison. Radiology 2004; 23:417–422CrossRef Agress H, Cooper BZ.: Detection of Clinically Unexpected Malignant and Premalignant Tumors with Whole-Body FDG-PET: Histopathology Comparison. Radiology 2004; 23:417–422CrossRef
18.
Zurück zum Zitat Israel O, Mor M, Guralnik L, et al.: 18F-FDG PET/CT Useful for Imaging and Management of Patients with Suspected Occult Recurrence of Cancer? J Nucl Med 2004; 45:2045–2051PubMed Israel O, Mor M, Guralnik L, et al.: 18F-FDG PET/CT Useful for Imaging and Management of Patients with Suspected Occult Recurrence of Cancer? J Nucl Med 2004; 45:2045–2051PubMed
19.
Zurück zum Zitat Kim S, Chung JK, Kim BT, et al.: Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET. Clin Positron Imaging 1999; 2:273–279.PubMedCrossRef Kim S, Chung JK, Kim BT, et al.: Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET. Clin Positron Imaging 1999; 2:273–279.PubMedCrossRef
20.
Zurück zum Zitat Weston BR, Iyer RB, Qiao W, et al.: Ability of Integrated Positron Emission and Computed Tomography to Detect Significant Colonic Pathology: The Experience of a Tertiary Cancer Center. Cancer 2010; 116:1454–1461.PubMedCrossRef Weston BR, Iyer RB, Qiao W, et al.: Ability of Integrated Positron Emission and Computed Tomography to Detect Significant Colonic Pathology: The Experience of a Tertiary Cancer Center. Cancer 2010; 116:1454–1461.PubMedCrossRef
21.
Zurück zum Zitat Yasuda S, Shohtsu A, Tsutsumi Y.: Colonic adenoma detected by positron emission tomography (PET): a case report. Tokai J Exp Clin Med 1998;23:153–155.PubMed Yasuda S, Shohtsu A, Tsutsumi Y.: Colonic adenoma detected by positron emission tomography (PET): a case report. Tokai J Exp Clin Med 1998;23:153–155.PubMed
22.
Zurück zum Zitat Zhuang H, Hickeson M, Chacko TK, et al.: Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules. Clin Nucl Med 2002;27:628–632.PubMedCrossRef Zhuang H, Hickeson M, Chacko TK, et al.: Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules. Clin Nucl Med 2002;27:628–632.PubMedCrossRef
23.
Zurück zum Zitat Yasuda S, Fujii H, Nakahara T, et al.: 18 F-FDG PET detection of colonic adenomas. J Nucl Med 2001;42:989–992.PubMed Yasuda S, Fujii H, Nakahara T, et al.: 18 F-FDG PET detection of colonic adenomas. J Nucl Med 2001;42:989–992.PubMed
24.
Zurück zum Zitat Van Kouwen MC, Nagengast FM, Jansen JB, et al.: 2-(18 F)-Fluoro-2-deoxy-dglucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 2005;23:3713–3717.PubMedCrossRef Van Kouwen MC, Nagengast FM, Jansen JB, et al.: 2-(18 F)-Fluoro-2-deoxy-dglucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 2005;23:3713–3717.PubMedCrossRef
25.
Zurück zum Zitat Wong WM, Mandir N, Goodlad RA, et al.: Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut. 2002;50:212-217.PubMedCrossRef Wong WM, Mandir N, Goodlad RA, et al.: Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut. 2002;50:212-217.PubMedCrossRef
26.
Zurück zum Zitat Smyth E, Schöder H, Strong VE, et al: A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-d-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer. 2012; doi:10.1002/cncr.27550. Smyth E, Schöder H, Strong VE, et al: A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-d-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer. 2012; doi:10.​1002/​cncr.​27550.
Metadaten
Titel
Clinical Significance of Incidental Colonic 18F-FDG Uptake on PET/CT Images in Patients with Gastric Adenocarcinoma
verfasst von
Jung Ho Shim
Joo Hyun O
Seong Il Oh
Han Mo Yoo
Hae Myung Jeon
Cho Hyun Park
Sung Hoon Kim
Kyo Young Song
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 10/2012
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-012-1941-3

Weitere Artikel der Ausgabe 10/2012

Journal of Gastrointestinal Surgery 10/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.